Comparative Clinical Evaluation of the Roche Elecsys and Abbott Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serology Assays for Coronavirus Disease 2019 (COVID-19) [0.03%]
罗氏Elecsys和雅培严重急性呼吸系统综合症冠状病毒2(SARS-CoV-2)血清学检测在2019冠状病毒病(COVID-19)中的比较临床评估研究
Shaun S Tan,Sharon Saw,Ka Lip Chew et al.
Shaun S Tan et al.
Context.—: The use of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serologic tests detects antibodies in the host, contributing to the identification of individuals who have been exposed to coronavirus di...
Comparative Clinical Evaluation of the Roche Elecsys and Abbott Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serology Assays for Coronavirus Disease 2019 (COVID-19) [0.03%]
罗氏和雅培严重急性呼吸系统综合征冠状病毒2型(SARS-CoV-2)血清学检测试剂盒的临床比较评估研究新型冠状肺炎(COVID-19)
Shaun S Tan,Sharon Saw,Ka Lip Chew et al.
Shaun S Tan et al.
Context.—: The use of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serologic tests detects antibodies in the host, contributing to the identification of individuals who have been exposed to coronavirus di...
Resurrecting the Hospital Autopsy: Impact of an Office of Decedent Affairs on Consent Rates, Providers, and Next-of-Kin [0.03%]
复苏医院尸检：死者事务办公室对同意率、提供者和死者的近亲属的影响
Justin E Juskewitch,Joan M Griffin,Joseph J Maleszewski et al.
Justin E Juskewitch et al.
Context.—: Autopsy rates have decreased dramatically despite providing important clinical information to medical practices and social benefits to decedents' families. ...
Resurrecting the Hospital Autopsy: Impact of an Office of Decedent Affairs on Consent Rates, Providers, and Next-of-Kin [0.03%]
让逝者安息：逝者事务办公室对尸检率、提供者和家属的影响
Justin E Juskewitch,Joan M Griffin,Joseph J Maleszewski et al.
Justin E Juskewitch et al.
Context.—: Autopsy rates have decreased dramatically despite providing important clinical information to medical practices and social benefits to decedents' families. ...
Defining Normal Healthy Term Newborn Automated Hematologic Reference Intervals at 24 Hours of Life [0.03%]
定义正常健康的足月新生儿出生后24小时自动化血液学参考区间
Barbara Ianni,Holly McDaniel,Elena Savilo et al.
Barbara Ianni et al.
Context.—: Automated analyzers have advanced the field of clinical hematology, mandating updated complete blood count (CBC) reference intervals (RIs) to be clinically useful. Contemporary newborn CBC RI publications are ...
Defining Normal Healthy Term Newborn Automated Hematologic Reference Intervals at 24 Hours of Life [0.03%]
定义正常足月新生儿生后24小时自动化血液检查参考区间
Barbara Ianni,Holly McDaniel,Elena Savilo et al.
Barbara Ianni et al.
Context.—: Automated analyzers have advanced the field of clinical hematology, mandating updated complete blood count (CBC) reference intervals (RIs) to be clinically useful. Contemporary newborn CBC RI publications are ...
The Effect of Direct Oral Anticoagulants on Antithrombin Activity Testing Is Abolished by DOAC-Stop in Venous Thromboembolism Patients [0.03%]
直接口服抗凝药对血浆抗凝血酶活性检测的影响在停用DOAC后消失：一项体外研究
Michał Ząbczyk,Joanna Natorska,Magdalena Kopytek et al.
Michał Ząbczyk et al.
Context.—: Direct oral anticoagulants (DOACs) may cause false negative results of antithrombin (AT) deficiency screening. Objective.—: ...
The Effect of Direct Oral Anticoagulants on Antithrombin Activity Testing Is Abolished by DOAC-Stop in Venous Thromboembolism Patients [0.03%]
直接口服抗凝药物对抗凝血酶活性检测的影响可通过停药解决：在静脉血栓栓塞患者中的研究结果
Michał Ząbczyk,Joanna Natorska,Magdalena Kopytek et al.
Michał Ząbczyk et al.
Context.—: Direct oral anticoagulants (DOACs) may cause false negative results of antithrombin (AT) deficiency screening. Objective.—: ...
Evaluating Mismatch Repair/Microsatellite Instability Status Using Cytology Effusion Specimens to Determine Eligibility for Immunotherapy [0.03%]
基于细胞学腹水标本评估错配修复/微卫星不稳定性状态以确定患者是否适合接受免疫治疗的疗效分析
Elizabeth M Jacobi,Gene Landon,Russell R Broaddus et al.
Elizabeth M Jacobi et al.
Context.—: The approval of pembrolizumab for treatment of patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) advanced cancers has led to increased requests for MSI and/or MMR immuno...
Evaluating Mismatch Repair/Microsatellite Instability Status Using Cytology Effusion Specimens to Determine Eligibility for Immunotherapy [0.03%]
采用细胞学积液标本评估错配修复/微卫星不稳定性状态以确定免疫治疗的适用性
Elizabeth M Jacobi,Gene Landon,Russell R Broaddus et al.
Elizabeth M Jacobi et al.
Context.—: The approval of pembrolizumab for treatment of patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) advanced cancers has led to increased requests for MSI and/or MMR immuno...